STOCK TITAN

MAZE (NASDAQ: MAZE) insider files Rule 144 to sell 29,772 shares of stock

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

MAZE insider Sekar Kathiresan has filed a notice to sell 29,772 shares of common stock under Rule 144. The planned sale, with an aggregate market value of $1,210,937.40, is to be executed through Morgan Stanley Smith Barney LLC on or about January 16, 2026 on the NASDAQ market. The filing notes that 48,119,444 shares of the issuer’s common stock were outstanding.

The 29,772 shares to be sold were acquired on January 16, 2026 via a stock option exercise from the issuer, paid for in cash. Over the prior three months, Kathiresan sold additional common shares, including 10,000 shares on December 4, 2025 for gross proceeds of $425,423.00 and 27,500 shares on November 21, 2025 for gross proceeds of $984,588.00.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many MAZE shares does Sekar Kathiresan plan to sell in this Form 144?

The notice shows that 29,772 shares of MAZE common stock are planned to be sold under Rule 144.

When is the planned sale date for MAZE (MAZE) shares under this Form 144?

The planned approximate date of sale for the 29,772 MAZE common shares is January 16, 2026, with trading listed for NASDAQ.

How were the 29,772 MAZE shares being sold acquired?

The 29,772 MAZE common shares were acquired on January 16, 2026 through a stock option exercise from the issuer, and the filing states that the exercise was paid for in cash.

Which broker is handling the planned MAZE share sale under Rule 144?

The filing lists Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, as the broker for the planned sale.

How many MAZE shares were outstanding at the time of this Form 144 notice?

The Form 144 states that 48,119,444 shares of MAZE common stock were outstanding.

What MAZE share sales has Sekar Kathiresan made in the past three months?

The filing reports two recent sales of MAZE common stock: 10,000 shares sold on December 4, 2025 for gross proceeds of $425,423.00, and 27,500 shares sold on November 21, 2025 for gross proceeds of $984,588.00.

What representation does the MAZE insider make in signing this Form 144?

By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, and similar representations apply if a Rule 10b5-1 trading plan or instructions have been adopted.

Maze Therapeutics

NASDAQ:MAZE

MAZE Rankings

MAZE Latest News

MAZE Latest SEC Filings

MAZE Stock Data

1.92B
42.04M
5.9%
88.63%
3.93%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO